|
Celcuity Inc (NASDAQ: CELC) |
|
Celcuity Inc
CELC's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Celcuity Inc 's sales fell
in the fourth quarter of 2024 from the same quarter a year ago.
Medical Laboratories industry recorded
growth of revenues by 6.22 %
Celcuity Inc net loss increased from $-26 millions, to $-37 millions in fourth quarter of 2024,
• More on CELC's Growth
|
|
Celcuity Inc realized a net loss in trailing twelve months.
Celcuity Inc realized cash reduction of $ -0.21 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Medical Laboratories industry's Price to Sales ratio is at 2.2.
• More on CELC's Valuation
|
|
|
|
|
Celcuity Inc realized net loss in trailing twelve months.
Celcuity Inc realized cash outflow of $ -0.21per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Medical Laboratories industry's Price to Sales ratio is at 2.2.
Celcuity Inc Price to Book Ratio is at 3.65 lower than Industry Avg. of 150.28. and higher than S&P 500 Avg. of 0.01
• More on CELC's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com